Gaede (2003)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetesNew England Journal of Medicine, 348
D. Kiortsis, P. Giral, Éric Bruckert, G. Turpin (2000)
Factors associated with low compliance with lipid‐lowering drugs in hyperlipidemic patientsJournal of Clinical Pharmacy and Therapeutics, 25
A. Tonkin, P. Alyward, D. Colquhoun, P. Glasziou, P. Harris, D. Hunt, A. Keech, S. MacMahon, P. Magnus, D. Newel, P. Nestel, N. Sharpe, J. Shaw, R. Simes, P. Thompson, A. Thompson, M. West, H. White, S. Simes, W. Hague, S. Caleo, Jane Hall, Andrew Martin, S. Mulray, P. Barter, L. Beilin, R. Collins, J. McNeil, P. Meier, H. Willimott, D. Smithers, P. Wallace, J. Baker, M. Hobbs, D. Sullivan, N. Anderson, G. Hankey, J. Watson, M. Arulchelvam, S. Chup, J. Daly, J. Hanna, A. Leach, M. Lee, J. Loughhead, H. Lundie-Jenkin, J. Morrison, S. Netting, A. Nguyen, H. Pater, R. Philip, G. Pinna, D. Rattos, S. Ryerson, V. Sazhin, R. Walsh, A. Claque, M. Mackie, J. Yallop, K. Boss, M. Shepard, J. Leach, M. Gandy, J. Joughin, J. Seabrook, R. Abraham, J. Allen, F. Bates, I. Beinart, E. Breed, D. Brown, N. Bunyan, D. Calvert, T. Campbell, D. Condon‐Paoloni, B. Conway, L. Coupland, J. Crowe, N. Cunio, B. Cuthbert, N. Cuthbert, S. D'arcy, P. Davidson, B. Dwyer, J. England, C. Friend, G. Fulcher, S. Grant, K. Hellestrand, M. Kava, L. Kritharides, D. McGill, H. McKee, A. Mclean, M. Neaverson, G. Nelson, M. O'Neill, C. Onuma, F. O'Reilly (1998)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.The New England journal of medicine, 339 19
F. Noel, R. Berringer, Urvashi Patel (2002)
Effect of early telephone and postal reminders on medication compliance with pravastatin therapy.Clinical therapeutics, 24 1
R. Tsuyuki, T. Bungard (2001)
Poor Adherence with Hypolipidemic Drugs: A Lost OpportunityPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 21
D. Lewis, Jude Robinson, E. Wilkinson (2003)
Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudesBMJ : British Medical Journal, 327
J. Avorn, J. Monette, A. Lacour, R. Bohn, M. Monane, H. Mogun, J. LeLorier (1998)
Persistence of use of lipid-lowering medications: a cross-national study.JAMA, 279 18
Karen Powell, B. Edgren (1995)
Failure of educational videotapes to improve medication compliance in a health maintenance organization.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 52 20
V. Micevski (2002)
Review: multidisciplinary disease management programmes do not reduce death or recurrent myocardial infarction but reduce admission to hospitalEvidence Based Nursing, 5
M. Moher, P. Yudkin, L. Wright, Rebecca Turner, A. Fuller, T. Schofield, D. Mant (2001)
Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary careBMJ : British Medical Journal, 322
Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE
(1990)
Kjelsberg 1990 {published data only} . Kjelsberg MO. Mortality after 10one-half years for hypertensive participants in the multiple risk factor intervention trial
J. Downs, M. Clearfield, S. Weis, E. Whitney, D. Shapiro, P. Beere, A. Langendorfer, E. Stein, W. Kruyer, A. Gotto (1998)
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.JAMA, 279 20
V. Athyros, A. Papageorgiou, Bodosakis Mercouris, V. Athyrou, A. Symeonidis, Elias Basayannis, D. Demitriadis, A. Kontopoulos (2002)
Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease PreventionCurrent Medical Research and Opinion, 18
E. Lesaffre, E. Klerk (2000)
Estimating the power of compliance-improving methods.Controlled clinical trials, 21 6
P. Burkett (1990)
Frequent cholesterol feedback as an aid in lowering cholesterol levelsJournal of Cardiopulmonary Rehabilitation, 10
H. Kopell (1978)
Compliance with Therapeutic RegimensPostgraduate Medical Journal, 54
Sherri Konzem, D. Gray, M. Kashyap (1997)
Effect of Pharmaceutical Care on Optimum Colestipol Treatment in Elderly Hypercholesterolemic VeteransPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 17
Anonymous (2001)
Pharmacist-managed lipid program reduces medication costs despite increase in drug utilizationHospital Formulary, 36
Allen (2000)
Cholesterol management: an opportunity for nurse case managersJournal of Cardiovascular Nursing, 14
Alvarez (2001)
Effectuve strategies to improve adherence to drug prescriptionMedifam - Revista de Medicina Familiar y Comunitaria, 11
Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts
M. Sweeney, B. Fletcher, C. Rice, K. Berra, C. Rudd, G. Fletcher, R. Superko (1991)
Efficacy and compliance with cholestyramine bar versus powder in the treatment of hyperlipidemia.The American journal of medicine, 90 4
Bozovich (2000)
Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goalsPharmacotherapy, 20
(2000)
Christmas Cards and CalendersBMJ : British Medical Journal, 321
M. Tully, E. Seston (2000)
Impact of Pharmacists Providing a Prescription Review and Monitoring Service in Ambulatory Care or Community PracticeAnnals of Pharmacotherapy, 34
J. Kinn, Michael O'Toole, Stephen Rowley, Joseph Marek, Vincent Bufalino, Alan Brown (2001)
Effectiveness of the electronic medical record in cholesterol management in patients with coronary artery disease (Virtual Lipid Clinic).The American journal of cardiology, 88 2
Robin (2002)
Patient adherence and medical treatment outcomes: a meta-analysisMedical Care, 40
Rodgers (2000)
Pharmacological interventions in type 2 diabetes: the role of nursesBritish Journal of Nursing, 9
(1999)
Stroup D for the QUORUM group. Improving the quality of reporting of meta-analyses of randomised controlled trials: the QUORUM statement
Vinod Diwan, Rolf Wahlström, Göran Tomson, Björn Beermann, Göran Sterky, Bo Eriksson (1995)
Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care.Journal of clinical epidemiology, 48 5
M. Faulkner, E. Wadibia, B. Lucas, D. Hilleman (2000)
Impact of Pharmacy Counseling on Compliance and Effectiveness of Combination Lipid‐Lowering Therapy in Patients Undergoing Coronary Artery Revascularization: A Randomized, Controlled TrialPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 20
H. Mäenpää, O. Heinonen, Vesa Manninen (1991)
Medication compliance and serum lipid changes in the Helsinki Heart Study.British journal of clinical pharmacology, 32 4
B. Brown, Joanna Bardsley, D. Poulin, L. Hillger, A. Dowdy, V. Maher, X. Zhao, J. Albers, R. Knopp (1997)
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease.The American journal of cardiology, 80 2
(2001)
Anon 2001(b) {published data only} . Anonymous. Risk factors for CHD not being identified
J. Benner, R. Glynn, H. Mogun, P. Neumann, M. Weinstein, J. Avorn (2002)
Long-term persistence in use of statin therapy in elderly patients.JAMA, 288 4
(2002)
The Cochrane Reviewers Handbook
L. Wright (2002)
The specialist nurse in coronary heart disease prevention: evidence for effectivenessthe british journal of cardiology, 9
E. Contreras, J. Martínez, M. Andrés, E. Prieto, J. Zamorano, J. García, J. Pablos, J. Fernández (1998)
[Therapeutic compliance in dyslipidemias. A trial of the efficacy of health education].Atencion primaria, 22 2
(2001)
Supporting the implementation of prescribing advice in PCOs
K. Schroeder, T. Fahey, S. Ebrahim (2004)
Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings.The Cochrane database of systematic reviews, 2
J. Urquhart (1994)
Role of patient compliance in clinical pharmacokinetics. A review of recent research.Clinical pharmacokinetics, 27 3
R. Friedman (1998)
Automated Telephone Conversations to Assess Health Behavior and Deliver Behavioral InterventionsJournal of Medical Systems, 22
Anonymous (2002)
Is alternate day dosing more cost-effective?Pharmaceutical Journal, 269
C. Jackevicius, M. Mamdani, J. Tu (2002)
Adherence with statin therapy in elderly patients with and without acute coronary syndromes.JAMA, 288 4
D. Becker, Jerilyn Allen (2001)
Improving Compliance in Your Dyslipidemic Patient: An Evidence‐based ApproachJournal of the American Academy of Nurse Practitioners, 13
(2004)
Adherence to long-term therapies
M. Clarke, Liz Greaves (1995)
Identifying relevant studies for systematic reviewsBMJ, 310
Schectman (1996)
Physician extenders for cost-effective management of hypercholesterolemiaJournal of General Internal Medicine, 11
C. Frances, P. Alperin, Josh Adler, D. Grady (2001)
Does a fixed physician reminder system improve the care of patients with coronary artery disease? A randomized controlled trial.The Western journal of medicine, 175 3
F. Sacks, M. Pfeffer, L. Moye, J. Rouleau, J. Rutherford, T. Cole, L. Brown, J. Warnica, J. Arnold, C. Wun, B. Davis, E. Braunwald (1996)
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.The New England journal of medicine, 335 14
Li Wei, J. Wang, P. Thompson, S. Wong, A. Struthers, T. MacDonald (2002)
Magnetic resonance imaging of left atrial thrombusHeart, 88
R. Tsuyuki, Jeffrey Johnson, K. Teo, S. Simpson, M. Ackman, Rosemarie Biggs, A. Cave, Wei-Ching Chang, V. Džavík, K. Farris, D. Galvin, W. Semchuk, Jeff Taylor (2002)
A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).Archives of internal medicine, 162 10
V. Athyros, D. Mikhailidis, A. Papageorgiou, Bodosakis Mercouris, V. Athyrou, A. Symeonidis, Elias Basayannis, D. Demitriadis, A. Kontopoulos (2002)
Attaining United Kingdom-European Atherosclerosis Society Low-density Lipoprotein Cholesterol Guideline Target Values in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) StudyCurrent Medical Research and Opinion, 18
Expert Panel on Detection , Evaluation and Treatment of High Blood Cholesterol in Adults ( ATP III ) . Third Report of the National Cholesterol Education Program ( NCEP )
manuscript; available in PMC
Jerilyn Allen, R. Blumenthal, S. Margolis, D. Young, E. Miller, K. Kelly (2002)
Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial.American heart journal, 144 4
W. Insull (1997)
The problem of compliance to cholesterol altering therapyJournal of Internal Medicine, 241
R. Tsuyuki, Jeffrey Johnson, K. Teo, M. Ackman, Rosemarie Biggs, A. Cave, Wei-Ching Chang, V. Džavík, K. Farris, D. Galvin, W. Semchuk, S. Simpson, Jeff Taylor (1999)
Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): A Randomized Trial Design of the Effect of a Community Pharmacist Intervention Program on Serum Cholesterol RiskAnnals of Pharmacotherapy, 33
T. Coates, R. Jeffery, L. Slinkard, J. Killen, B. Danaher (1982)
Frequency of contact and monetary reward in weight loss, lipid change, and blood pressure reduction with adolescents *Behavior Therapy, 13
T. Keyserling, A. Ammerman, C. Davis, Mario Mok, J. Garrett, Ross Simpson (1997)
A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project.Archives of family medicine, 6 2
Johannesson (1996)
The cost effectiveness of lipid lowering in Swedish primary health care. The CELL Study GroupJournal of Internal Medicine, 240
J. Stephenson (2004)
World health report.Lancet, 2 7717
(2001)
Picon Garcia dL. Effectuve strategies to improve adherence to drug prescription
Bogden (1997)
The physician and pharmacist team. An effective approach to cholesterol reductionJournal of General Internal Medicine, 12
A. Schwed, C. Fallab, M. Burnier, B. Waeber, L. Kappenberger, B. Burnand, R. Darioli (1999)
Electronic Monitoring of Compliance to Lipid‐Lowering Therapy in Clinical PracticeThe Journal of Clinical Pharmacology, 39
A. Zermansky, D. Petty, D. Raynor, C. Lowe, N. Freemantle, A. Vail (2002)
Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial.Health technology assessment, 6 20
S. Ellis, B. Carter, D. Malone, S. Billups, G. Okano, R. Valuck, D. Barnette, C. Sintek, D. Covey, B. Mason, S. Jue, J. Carmichael, K. Guthrie, R. Dombrowski, D. Geraets, M. Amato (2000)
Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.Pharmacotherapy, 20 12
Poston (1998)
The medication use studyCanadian Pharmaceutical Journal, 131
P. Mullen, L. Green, G. Persinger (1985)
Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types.Preventive medicine, 14 6
(2004)
Section 6 Assessment of study quality. Cochrane Reviewers
Kuznar (2002)
Protocol helps drug adherenceCardiology Review, 19
J. Shepherd, S. Cobbe, I. Ford, C. Isles, A. Lorimer, P. Macfarlane, J. Mckillop, C. Packard (1995)
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.The New England journal of medicine, 333 20
S. Simpson, Jeffrey Johnson, R. Tsuyuki (2001)
Economic Impact of Community Pharmacist Intervention in Cholesterol Risk Management: An Evaluation of the Study of Cardiovascular Risk Intervention by PharmacistsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 21
R. Rachmani, Z. Levi, Inna Slavachevski, M. Avin, M. Ravid (2002)
Teaching patients to monitor their risk factors retards the progression of vascular complications in high‐risk patients with Type 2 diabetes mellitus—a randomized prospective studyDiabetic Medicine, 19
M. Senaratne, J. Griffiths, D. Mooney, L. Kasza, K. MacDonald, S. Hare (2001)
Effectiveness of a planned strategy using cardiac rehabilitation nurses for the management of dyslipidemia in patients with coronary artery disease.American heart journal, 142 6
Ives (1993)
Use and outcomes of a cholesterol-lowering intervention for rural elderly subjectsAmerican Journal of Preventive Medicine, 9
(2001)
Anon 2001(a) {published data only} . Anonymous. Pharmacist-managed lipid program reduces medication costs despite increase in drug utilization
L. DiTusa, A. Luzier, P. Brady, R. Reinhardt, B. Snyder (2001)
A pharmacy-based approach to cholesterol management.The American journal of managed care, 7 10
(2000)
Low-densitylipoprotein cholesterol in patients treated by a lipid clinic versus a primary care clinic
Urquhart (1999)
Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimensPharmacoeconomics, 15
Y. W., Fujimoto (2000)
The Diabetes Prevention Program Baseline characteristics of the randomized cohort
J. Shaffer, L. Wexler (1995)
Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.JAMA Internal Medicine, 155
L. Scherwitz, O. Brusis, D. Kesten, P. Safian, E. Hasper, A. Berg, J. Siegrist (1995)
[Life style changes in patients with myocardial infarct in the framework of intramural and ambulatory rehabilitation--results of a German pilot study].Zeitschrift fur Kardiologie, 84 3
Kate Jolly, F. Bradley, S. Sharp, Helen Smith, D. Mant (1998)
Follow-up care in general practice of patients with myocardial infarction or angina pectoris: initial results of the SHIP trial. Southampton Heart Integrated Care Project.Family practice, 15 6
S. Assmann, S. Pocock, L. Enos, L. Kasten (2000)
Subgroup analysis and other (mis)uses of baseline data in clinical trialsThe Lancet, 355
D. Roter, Judith Hall, Rolande Merisca, B. Nordstrom, Deborah Cretin, B. Svarstad (1998)
Effectiveness of interventions to improve patient compliance: a meta-analysis.Medical care, 36 8
J. Rindone, D. Hiller, Greg Arriola (1998)
A Comparison of Fluvastatin 40 mg Every Other Day versus 20 mg Every Day in Patients with HypercholesterolemiaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 18
R. Wahlström, G. Tomson, V. Diwan, B. Beermann, G. Sterky (1995)
Hyperlipidaemia in primary care — a randomized controlled trial on treatment information in Sweden: Design and methodologyPharmacoepidemiology and Drug Safety, 4
Margarite Vale, M. Jelinek, J. Best, J. Santamaria (2002)
Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the "real world"--randomized controlled trial.Journal of clinical epidemiology, 55 3
M. Kirkman, M. Weinberger, P. Landsman, G. Samsa, E. Shortliffe, D. Simel, J. Feussner (1994)
A Telephone-Delivered Intervention for Patients With NIDDM: Effect on coronary risk factorsDiabetes Care, 17
(1996)
The CELL Study Group. The cost effectiveness of lipid lowering in Swedish primary health care
E. Bruckert, Christine Simonetta, P. Giral (1999)
Compliance with fluvastatin treatment characterization of the noncompliant population within a population of 3845 patients with hyperlipidemia. CREOLE Study Team.Journal of clinical epidemiology, 52 6
P. Gæde, P. Vedel, H. Parving, O. Pedersen (1999)
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 353
M. Eriksson, K. Hådell, I. Holme, G. Walldius, T. Kjellström (1997)
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.Journal of internal medicine, 243 5
Kjelsberg (1990)
Mortality after 10one-half years for hypertensive participants in the multiple risk factor intervention trialCirculation, 82
Heather Copher, R. Stewart (2002)
Daily Dosing versus Alternate‐Day Dosing of Simvastatin in Patients with HypercholesterolemiaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 22
K. Oi, H. Komori (1998)
Escape phenomenon with pravastatin during long-term treatment of patients with hyperlipidemia associated with diabetes mellitusCurrent Therapeutic Research-clinical and Experimental, 59
Wei (2002)
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up studyHeart (British Cardiac Society), 88
(2002)
Kuznar 2002 {published data only} . Kuznar W. Protocol helps drug adherence
Judith Larosa, John LaRosa (2000)
Enhancing drug compliance in lipid-lowering treatment.Archives of family medicine, 9 10
F. Piñeiro, V. Gil, M. Donis, D. Orozco, M. Torres, J. Merino (1997)
[The validity of 6 indirect methods for assessing compliance with pharmacological treatment in dyslipidemias].Atencion primaria, 19 9
L. Lindholm, T. Ekbom, C. Dash, Å. Isacsson, B. Scherstén (1996)
Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL StudyJournal of Internal Medicine, 240
Anonymous (2001)
Risk factors for CHD not being identifiedBritish Journal of Cardiology, 8
Young Kim, S. Sunwoo, Hye Lee, Keun Lee, Yong Park, Ho Shin, Cheol Kim, Dae Kim, Byung Kim, Hyeong Cha, Bong Huh (2002)
Determinants of non‐compliance with lipid‐lowering therapy in hyperlipidemic patientsPharmacoepidemiology and Drug Safety, 11
(2002)
Heart Protection Study Collaborative Group. MRC/BHF Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebocontrolled trial
DeBusk (1994)
A case-management system for coronary risk factor modification after acute myocardial infarctionAnnals of Internal Medicine, 120
J. Baillargeon, S. Lepage, L. Larrivée, M. Roy, S. Landry, P. Maheux (2001)
Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: evaluation of a nurse-oriented management approach.The Canadian journal of cardiology, 17 2
D. Becker, Judith Raqueño, R. Yook, B. Kral, R. Blumenthal, T. Moy, P. Bezirdjian, Lewis Becker (1998)
Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease.Archives of internal medicine, 158 14
Peter Wilmshurst (1997)
Brain damage in diversBMJ, 314
D. O'Donnell, N. Chen, V. Piziak (2001)
Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 58 4
S. Ebrahim, S. Davey (2000)
In people with no evidence of cardiovascular disease, how effective are interventions aimed at controlling risk factors in reducing all-cause and coronary artery disease mortality?The Western journal of medicine, 173 3
R. Straka, J. Fish, S. Benson, J. Suh (1997)
Patient Self‐Reporting of Compliance Does Not Correspond with Electronic Monitoring: An Evaluation Using Isosorbide Dinitrate as a Model DrugPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 17
G. Schectman, J. Hiatt, A. Hartz (1994)
Telephone Contacts Do Not Improve Adherence to Niacin or Bile Acid Sequestrant TherapyAnnals of Pharmacotherapy, 28
(1991)
Research connections: treating hypercholesterolemia
S. Rueda, L. Park-Wyllie, A. Bayoumi, A. Tynan, T. Antoniou, S. Rourke, R. Glazier (2006)
Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.The Cochrane database of systematic reviews, 3
L. Casebeer, J. Klapow, R. Centor, M. Stafford, L Renkl, A. Mallinger, R. Kristofco (1999)
An intervention to increase physicians' use of adherence-enhancing strategies in managing hypercholesterolemic patients.Academic medicine : journal of the Association of American Medical Colleges, 74 12
H. Mäenpää, V. Manninen, O. Heinonen (1987)
Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial.European heart journal, 8 Suppl I
R. Guthrie (2001)
The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program.Clinical therapeutics, 23 6
(2003)
{unpublished data only} . Improved compliance and persistence with atorvastatin through a pharmacy -based intervention. Ongoing study not reported
A. Dobs, Rebecca Masters, L. Rajaram, F. Stillman, L. Wilder, S. Margolis, D. Becker (1994)
A comparison of education methods and their impact on behavioral change in patients with hyperlipidemia.Patient education and counseling, 24 2
E. Vermeire, H. Hearnshaw, P. Royen, J. Denekens (2001)
Patient adherence to treatment: three decades of research. A comprehensive reviewJournal of Clinical Pharmacy and Therapeutics, 26
D. O'Donnell, C. Brown, V. Piziak (2001)
Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 58 11
C. Ellis, T. O’Meeghan, A. Hamer, G. Gordon, H. Patel (1998)
Evidence based strategies for secondary prevention of ischaemic heart disease: time to improve clinical practice.The New Zealand medical journal, 111 1065
J. Larosa (2000)
Poor compliance: The hidden risk factorCurrent Atherosclerosis Reports, 2
Rastam (1996)
Nurses counseling for hypercholesterolemia: Efficient strategy in middle-aged menCardiovascular Risk Factors, 6
R. Haynes, P. Montague, T. Oliver, K. McKibbon, M. Brouwers, R. Kanani (2002)
Interventions for helping patients to follow prescriptions for medications.The Cochrane database of systematic reviews, 2
Disciplinary Committee, John Samuels, Peter Jones (2002)
Royal Pharmaceutical Society of Great Britain
B. Vergès, B. Patois-Vergès, M. Cohen, J. Casillas (1998)
Comprehensive cardiac rehabilitation improves the control of dyslipidemia in secondary prevention.Journal of cardiopulmonary rehabilitation, 18 6
P. Merriam, I. Ockene, J. Hébert, Y. Ma (1997)
A lipid trial tracking system.Journal of public health management and practice : JPHMP, 3 6
E. Velonakis, P. Sourtzi, N. Komitopoulos, J. Ioannides, E. Varsamis (1999)
A health promotion programme for the prevention of cardiovascular diseases in the elderlyInternational journal of health promotion and education, 37
Cochrane Database of Systematic Reviews – Unpaywall
Published: Oct 14, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.